Ann Cunningham

Direttore/Membro del Consiglio presso VISTAGEN THERAPEUTICS, INC.

Patrimonio netto: - $ in data 31/05/2024

56 anni

Health Technology

Consumer Services

Posizioni attive di Ann Cunningham

Società	Posizione	Inizio	Fine
VISTAGEN THERAPEUTICS, INC.	Direttore/Membro del Consiglio	10/01/2019	-
	Independent Dir/Board Member	10/01/2019	-
	Corporate Officer/Principal	01/05/2021	01/11/2022

Società	Posizione	Inizio	Fine
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Corporate Officer/Principal	01/01/2015	01/01/2018
ELI LILLY AND COMPANY	Corporate Officer/Principal	01/01/1999	01/01/2013
Otsuka America Pharmaceutical, Inc. Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD.	Corporate Officer/Principal	-	-
I3 Strategy Partners LLC	Fondatore	-	-
I3 Strategy Partners LLC	Corporate Officer/Principal	-	-

Yale University	Undergraduate Degree
Stephen M. Ross School of Business	Masters Business Admin

Distribuzione geografica

Stati Uniti	7
Israele	2

Posizioni

Corporate Officer/Principal	5
Director/Board Member	1
Independent Dir/Board Member	1

Settori

Health Technology	5
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	3
VISTAGEN THERAPEUTICS, INC.	Health Technology
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Health Technology
ELI LILLY AND COMPANY	Health Technology

Aziende private	2
I3 Strategy Partners LLC
Otsuka America Pharmaceutical, Inc. Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD.	Health Technology